Neochem Bio Solutions Ltd
Incorporated in 2006, Neochem Bio Solutions Ltd. is engaged in the business of manufacturing of specialty performance chemicals.[1]
- Market Cap ₹ 170 Cr.
- Current Price ₹ 99.2
- High / Low ₹ 121 / 63.0
- Stock P/E 13.6
- Book Value ₹ 46.0
- Dividend Yield 0.00 %
- ROCE 28.0 %
- ROE 25.3 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.8%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 161 days.
- Working capital days have increased from 77.3 days to 164 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of Nifty SME Emerge
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 49 | 48 | 61 | 84 | 111 | |
| 45 | 44 | 55 | 71 | 91 | |
| Operating Profit | 4 | 4 | 6 | 13 | 20 |
| OPM % | 7% | 9% | 10% | 15% | 18% |
| 0 | 1 | 1 | 2 | 2 | |
| Interest | 1 | 2 | 3 | 4 | 4 |
| Depreciation | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 1 | 2 | 3 | 10 | 17 |
| Tax % | 25% | 28% | 31% | 25% | 30% |
| 1 | 1 | 2 | 7 | 12 | |
| EPS in Rs | 3.23 | 2.10 | 2.89 | 11.15 | 7.03 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 32% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 122% |
| TTM: | 67% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 28% |
| 3 Years: | 29% |
| Last Year: | 25% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 3 | 5 | 7 | 7 | 17 |
| Reserves | 1 | 3 | 6 | 13 | 62 |
| 23 | 26 | 33 | 36 | 18 | |
| 19 | 16 | 18 | 23 | 20 | |
| Total Liabilities | 46 | 51 | 63 | 78 | 117 |
| 12 | 15 | 19 | 19 | 20 | |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 6 |
| 34 | 36 | 45 | 60 | 91 | |
| Total Assets | 46 | 51 | 63 | 78 | 117 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| -1 | -1 | -1 | 2 | -19 | |
| -3 | -3 | 12 | 2 | -7 | |
| 4 | 4 | -11 | -4 | 26 | |
| Net Cash Flow | 0 | -0 | 0 | -0 | 0 |
| Free Cash Flow | -4 | -4 | 11 | 4 | -22 |
| CFO/OP | -36% | -23% | -10% | 17% | -81% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 102 | 107 | 100 | 108 | 161 |
| Inventory Days | 141 | 173 | 172 | 157 | 143 |
| Days Payable | 186 | 155 | 142 | 117 | 56 |
| Cash Conversion Cycle | 58 | 125 | 131 | 148 | 247 |
| Working Capital Days | 17 | 19 | 30 | 38 | 164 |
| ROCE % | 12% | 14% | 27% | 28% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Actual Production Volume MT |
|
||
| Capacity Utilization % |
|||
| Installed Production Capacity MTPA |
|||
| Number of Domestic Customers count |
|||
| Number of Export Countries count |
|||
| Number of Export Customers count |
|||
Extracted by Screener AI
Documents
Announcements
-
Analysts/Institutional Investor Meet/Con. Call Updates
27 May 2026 - FY26 revenue rose 32% to ₹110.7 crore; EBITDA reached ₹22.6 crore and PAT ₹12 crore.
-
Analysts/Institutional Investor Meet/Con. Call Updates
23 May 2026 - Audio recording of investor call held on May 22, 2026 uploaded.
-
Investor Presentation
20 May 2026 - Company submitted FY26 investor presentation under Regulation 30.
-
Analysts/Institutional Investor Meet/Con. Call Updates
19 May 2026 - Neochem Bio Solutions schedules H2FY26 earnings call on May 22, 2026 at 2:00 PM IST.
-
Outcome of Board Meeting
18 May 2026 - Board approved audited FY26 results on 18 May 2026; revenue Rs 11,069.94 lakh, PAT Rs 1,202.66 lakh.
Concalls
-
May 2026Transcript PPT
-
Mar 2026TranscriptAI SummaryPPT
Business Profile[1]
Operates as a specialty performance chemical company with 350+ customized formulations across four primary product segments, ''Polymers, Surfactants, Silicones and esters/bio-based sustainable solutions''.